Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abaxis

This article was originally published in The Gray Sheet

Executive Summary

Plans to submit a 510(k) for its EPOC 2000 blood-chemistry analyzer during the third quarter of 1993. The EPOC 2000 is a point-of-care diagnostic instrument that can perform multiple blood tests in under 10 minutes ("The Gray Sheet" Dec. 23, 1991, p. 5). The 510(k) filing will cover five tests, and the firm says that a second filing for a "full complement of tests" will take place following FDA clearance of the original 510(k). Abaxis recently revised the rotor of the EPOC 2000 to correct deficiencies seen with a prototype version of the device. The redesigned device can separate the patient's whole blood and measure the plasma sample with "the desired level of accuracy," the firm says.
UsernamePublicRestriction

Register

MT000384

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel